Inhibition of ligand‐independent constitutive activation of the Met oncogenic receptor by the engineered chemically‐modified antibody DN30

অনুযায়ী Vigna, Elisa, Chiriaco, Cristina, Cignetto, Simona, Fontani, Lara, Basilico, Cristina, Petronzelli, Fiorella, Comoglio, Paolo M.
প্রকাশিত Mol Oncol (2015)

Dual Constant Domain‐Fab: A novel strategy to improve half‐life and potency of a Met therapeutic antibody

অনুযায়ী Cignetto, Simona, Modica, Chiara, Chiriaco, Cristina, Fontani, Lara, Milla, Paola, Michieli, Paolo, Comoglio, Paolo M., Vigna, Elisa
প্রকাশিত Mol Oncol (2016)